Capital Cell
Capital Cell is a Barcelona-based equity crowdfunding platform founded in 2014 that connects early-stage biotech, medtech, and life sciences startups with individual and professional investors across Europe under the EU ECSP regulatory framework.
- Company typePrivate
- Founded2014
- HeadquartersBarcelona, Spain
- Headcount11–50
- GTM typeB2B
- OfferingDigital Commerce or Content
What Capital Cell does
Capital Cell is a Barcelona-based equity crowdfunding platform founded in 2014, specializing in connecting early-stage startups — predominantly in biotechnology, medtech, and life sciences — with individual and professional investors across Europe. The platform operates within the EU ECSP (European Crowdfunding Service Provider) regulatory framework, enabling cross-border equity crowdfunding campaigns compliant with European regulations. Capital Cell serves two primary customer segments: early-stage startups and spin-offs (e.g., EVis Bioscience AG, 2EyesVision) seeking pre-seed and seed capital, and individual and professional investors seeking access to early-stage investment opportunities outside traditional venture capital channels.
The platform's core offering is a marketplace where companies list investment opportunities and investors participate directly through online campaigns. Capital Cell generates revenue through commissions on successful funding completions (marketplace commission model). The platform has demonstrated ability to syndicate with institutional and government investors, as evidenced by 2EyesVision's €1M round co-invested by Bullnet Capital and CDTI. Recent deal flow indicates oversubscribed rounds (EVis Bioscience exceeded target by 5.5%), signaling investor demand within the niche.
Capital Cell has raised approximately $1.95M in disclosed funding across multiple rounds since 2016, including a $488,590 round from Spain's national innovation agency ENISA in January 2024. The company operates with 11-50 employees and is privately held. Leadership includes Nigel Ten Fleming as Chairman, Daniel Oliver as Director, Roi Villar Vázquez as Communications/Scientific/Marketing Manager, and Joan Marcos as General Manager. The company's value proposition centers on providing regulatory-compliant cross-border access to biotech and life sciences investment opportunities, distinguishing it from generalist crowdfunding platforms.
Capital Cell firmographics
Firmographics- Name
- Capital Cell
- Website
- https://capitalcell.es
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Capital Cell is a Barcelona-based equity crowdfunding platform founded in 2014 that connects early-stage biotech, medtech, and life sciences startups with individual and professional investors across Europe under the EU ECSP regulatory framework.
- Ownership category
- akta.pro rank
Capital Cell industry classification
Industry- Product category
- Equity Crowdfunding Platform
- NAICS
- Investment Banking and Securities Intermediation (523150)
- SIC
- Security Brokers, Dealers & Flotation Companies (6211)
- akta.pro primary industry
- Venture Capital Fundraising Placement (FSAEALAC)
- akta.pro secondary industries
- Capital Raising Advisory (Debt/Equity/Private Capital) (BPAHADAG), Institutional Capital Introduction (LP/Family Office/Endowment Matching) (FSAEALAI)
Keywords
Where Capital Cell is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Markets served
Capital Cell business model
Business model- GTM type
- B2B
- Offering type
- Digital Commerce or Content
- Cost components
- Technology or R&D, Marketing or Sales, Personnel, Operations, Others
Revenue model
- Crowdfunding Platform Fees: Capital Cell generates revenue by facilitating equity crowdfunding rounds, charging fees or commissions on successful funding completions. Companies like EVis Bioscience and 2EyesVision have used the platform to raise capital from investors.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Capital Cell product offering
Product offeringCore offering
Capital Cell operates an equity crowdfunding platform headquartered in Barcelona, Spain, that connects early-stage startups — with a specialized focus on biotech and life sciences companies — with retail and professional investors. The platform is registered under the European Crowdfunding Service Providers (ECSP) Regulation, enabling cross-border equity offerings across EU member states. Capital Cell earns revenue through commissions on successfully closed funding rounds, including transactions such as EVis Bioscience (€740K pre-seed) and 2EyesVision (€1M).
Product overview
Capital Cell is an equity crowdfunding platform specialized in biotech and life sciences companies. Based on the available source data, no detailed product portfolio, modules, or named offerings have been identified. The sources reference the platform as a funding vehicle where companies like EVis Bioscience, 2EyesVision, and other biotech startups have conducted funding rounds, but no specific platform products, features, or services are described.
Differentiator
Problem solved
Functional benefit
Products and services
- Capital Cell Equity Crowdfunding Platform
Quantifiable outcome
- European equity crowdfunding market raised €280 million in 2025 through 354 public equity campaigns
Companies that use Capital Cell
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Capital Cell technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Capital Cell partnerships and signals
Strategic signalRecent moves2 records
Expansion highlights4 records
Capital Cell competitors and assessment
Company assessmentDirect peers
- Seedrs (Republic Europe): Pan-European equity crowdfunding platform offering primary and secondary market access to retail and professional investors. Most direct competitor to Capital Cell, operating at significantly larger scale and now part of US-based Republic.
- Crowdcube: UK-headquartered equity crowdfunding platform serving high-growth startups across Europe. Acquired by Euronext, giving it deep capital backing — directly comparable to Capital Cell's core offering but at much greater scale.
- Companisto: Germany-based equity and convertible crowdfunding platform focused on growth-stage startups. Comparable in model (online marketplace, fee-based, retail/professional investors) and competes for the same European early-stage deal pool.
- WiSEED: French equity crowdfunding platform specializing in startups and SMEs, with strong fintech and impact-investing segments. Comparable to Capital Cell as a regulated continental European crowdfunding intermediary.
- Invesdor: Nordic (Finland-based) equity and debt crowdfunding platform operating across Europe under ECSP. Directly comparable in regulatory positioning and target issuer base.
Broad incumbents
- Republic: US-headquartered online investment platform offering equity, debt, and real-estate crowdfunding to retail investors. Acquired Seedrs in 2022 to expand into Europe, positioning it as a broad incumbent and direct competitor to Capital Cell in cross-border deals.
- Wefunder: US equity crowdfunding platform with a large retail-investor community and active deal flow. Operates primarily in the US but serves as a comparable platform model and indirect competitor for European issuers seeking international capital.
- Crowdcube (Euronext): Crowdcube under Euronext ownership combines retail crowdfunding with access to Euronext's institutional capital-markets infrastructure, making it a broad incumbent capable of supporting later-stage and follow-on rounds Capital Cell cannot easily facilitate.
Emerging players
- The Venture City: Spain-based early-stage investor and venture builder. Comparable to Capital Cell in Spain-centric biotech/tech deal sourcing, though operating via traditional VC structures rather than crowdfunding.
Others
- Enisa (ENISA): Spanish government-backed SME funding entity that participated in a $488,590 funding round for Capital Cell. Not a peer in the crowdfunding sense, but a relevant ecosystem counterparty as both a capital provider and provider of patient capital to early-stage Spanish companies.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Capital Cell social profiles
Digital presenceCapital Cell financial estimates
Financial estimateRevenue estimate
Valuation estimate
Capital Cell leadership team
Management profileNumber of profiles
Profiles4 records
Capital Cell funding detail
Funding detailFunding overview
Funding rounds4 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Capital Cell M&A and investment
M&A and investmentM&A
Investments52 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Capital Cell
What does Capital Cell do?
Capital Cell operates an equity crowdfunding platform headquartered in Barcelona, Spain, that connects early-stage startups — with a specialized focus on biotech and life sciences companies — with retail and professional investors. The platform is registered under the European Crowdfunding Service Providers (ECSP) Regulation, enabling cross-border equity offerings across EU member states. Capital Cell earns revenue through commissions on successfully closed funding rounds, including transactions such as EVis Bioscience (€740K pre-seed) and 2EyesVision (€1M).
Is Capital Cell a public or private company?
Capital Cell is a private company. It is classified as unknown and is currently operating.
When was Capital Cell founded?
Capital Cell was founded in 2014. It employs 11 to 50 people.
Where is Capital Cell based?
Capital Cell is headquartered in Barcelona, Spain, in the Europe region.
How does Capital Cell make money?
One revenue line is on record: crowdfunding Platform Fees.
Who are Capital Cell's main competitors?
Direct peers on record are Seedrs (Republic Europe), Crowdcube, Companisto, WiSEED and Invesdor. Broad incumbents are Republic, Wefunder and Crowdcube (Euronext). The Venture City is listed as an emerging player. Enisa (ENISA) is listed as an others.
Does Capital Cell have an API?
No public API is recorded for Capital Cell.
What industry is Capital Cell in?
Capital Cell's product category is Equity Crowdfunding Platform. Its primary akta.pro industry code is FSAEALAC, Venture Capital Fundraising Placement, with a secondary code of BPAHADAG, Capital Raising Advisory (Debt/Equity/Private Capital). Its NAICS code is 523150 and its SIC code is 6211.